Sunesis Pharmaceuticals to Present at the 40th Annual Cowen Health Care Conference
February 25 2020 - 4:05PM
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that
Willie Quinn, Chief Financial Officer and Senior Vice President,
Finance and Corporate Development of Sunesis, will present at the
40th Annual Cowen Health Care Conference on Tuesday, March 3, 2020
at 10:00 AM Eastern Standard Time in Boston, Massachusetts. The
presentation will be followed by a 30-minute breakout session at
10:40 AM Eastern Standard Time.
A live webcast of the presentation and breakout
session will be available on the Sunesis website at
http://ir.sunesis.com. A replay will be archived on the
"Calendar of Events" page in the Investors and Media section of the
Sunesis website for two weeks.
About Sunesis
Pharmaceuticals
Sunesis is a biopharmaceutical company
developing novel targeted inhibitors for the treatment of
hematologic and solid cancers. Sunesis has built an experienced
drug development organization committed to improving the lives of
people with cancer. The Company is focused on advancing its novel
kinase inhibitor pipeline, including its oral non-covalent BTK
inhibitor vecabrutinib and PDK1 inhibitor SNS-510. Vecabrutinib is
currently being evaluated in a Phase 1b/2 study in adults with
chronic lymphocytic leukemia and other B-cell malignancies that
have progressed after prior therapies.
For additional information on Sunesis, please
visit www.sunesis.com.
SUNESIS and the logos are trademarks of Sunesis
Pharmaceuticals, Inc.
Investor and Media
Inquiries:Maeve ConneightonArgot Partners212-600-1902 |
Willie
QuinnSunesis Pharmaceuticals Inc.650-266-3716 |
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Apr 2023 to Apr 2024